Fumarate copolymer–chitosan cross-linked scaffold directed to osteochondrogenic






© 2016  WILEY-VCH Verlag GmbH &  Co.  KGaA, Weinheim DOI: 10.1002/mabi.201600219
poor regenerative capacity after injury or degenerative dis-
eases.[1] After damage osteochondral tissue often requires 
surgical procedures for the regeneration of the lesions. The 
surgical approach depends on the size of the lesion, but for 
lesions larger than 2.5 cm2 it is necessary the use of some 
biomaterial is needed to promote tissue regeneration. The 
materials proposed to be used in osteochondral tissue 
reparation include protein derived polymers (i.e., collagen, 
fibrin), carbohydrate-based matrices (i.e., alginate, agarose, 
chitosan) or synthetic polymers (usually polyesters, poly-
fumarates).[2,3] Although most of the biomaterials used are 
based on homopolymers some authors proposed physical 
mixtures or cross-linked polymers.[2,4] Natural polymers 
are a matter of intense research because of their high 
biocompatibility and low toxicity. However, their weak 
mechanical properties and the noncontrolled degradation 
rate have led to the design of composite materials between 
synthetic and natural polymers.[3,5,6]
Chitosan is a natural polymer derived from chitin, 
widely studied for biomedical applications.[7–11] The 
Natural and synthetic cross-linked polymers allow the improvement of cytocompatibility and 
mechanical properties of the individual polymers. In osteochondral lesions of big size it will 
be required the use of scaffolds to repair the lesion. In this work a borax cross-linked scaffold 
based on fumarate-vinyl acetate copolymer and chitosan directed to osteochondrondral tissue 
engineering is developed. The cross-linked scaffolds and physical blends of the polymers are 
analyzed in based on their morphology, glass transition temperature, and mechanical proper-
ties. In addition, the stability, degradation behavior, and the 
swelling kinetics are studied. The results demonstrate that 
the borax cross-linked scaffold exhibits hydrogel behavior 
with appropriated mechanical properties for bone and car-
tilage tissue regeneration. Bone marrow progenitor cells and 
primary chondrocytes are used to demonstrate its osteo- and 
chondrogenic properties, respectively, assessing the osteo- 
and chondroblastic growth and maturation, without evident 
signs of cytotoxicity as it is evaluated in an in vitro system.
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1. Introduction
Ostochondral tissue designs a special interfacial zone 
between bone and cartilage which is highly organized and 
plays a critical role in maintaining the cartilage tissue. The 
a-vascular nature of cartilage tissue is the reason for the 
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choice of chitosan for tissue engineering is supported by 
its chemical nature, which in turn provides many pos-
sibilities for covalent and ionic modification that allows 
the adjustment of its mechanical and biological prop-
erties.[10] Different approaches to improve the phys-
icochemical properties of chitosan were developed, i.e., 
blending it with natural or synthetic polymers. Blending 
of two or more polymers has gradually become an impor-
tant approach to develop new biomaterials since no indi-
vidual polymer completely meets the requirements of the 
tissue. As a consequence the resulting mix of polymers 
exhibits properties which are a combination of their pri-
mary material properties.[12] However, in most cases there 
is some degree of incompatibility between the polymers 
that produce a blend of poor quality. In such cases, one 
strategy to improve the materials compatibility is polymer 
cross-linking achieved by the use of cross-linkers.[11,13–17]
In the present study we developed and characterized 
a new scaffold which was obtained by the cross-linking 
between a fumarate-based copolymer and chitosan. We 
studied its mechanical and swelling behavior as well as 
its aqueous stability and enzymatic-mediated degrada-
tion pattern. We also evaluated the scaffold in vitro bio-
compatibility using bone marrow progenitor cells (BMPC) 
and primary chondrocytes to evaluate cell growth kinetic 




Vinyl acetate (VA, 99%), isopropyl alcohol, and benzoyl peroxide 
(BP, recrystallized from methanol) were purchased from Merck 
(Buenos Aires, Argentina). Fumaric acid was gifted by Maleic S.A., 
Argentina. Diisopropyl fumarate (DIPF) monomer was prepared 
and purified as previously described.[18] Borax, Timper Laborato-
rios (99.9%) and other solvents were supplied by from Merck and 
Sintorgan. Chitosan (Sigma-Aldrich, high molecular weight) was 
used as received. The degree of acetylation (DA) of chitosan, was 
assessed by Fourier transform infrared (FTIR) based on the absorb-
ance ratio at 1320 and 1456 cm−1, corresponding to amide III and 
CH2 bands, respectively, as suggested by Brugnerotto et al.[19]
( )( ) = −DA % 31.92 A /A 12.201320 1456  (1)
The viscosity average molecular weight (Mη) of chitosan was 
evaluated by capillary viscometry using acetic acid 0.3 m/sodium 
acetate 0.2 m buffer as solvent. The measurement temperature 




 = ηαK M
mL
g  (2)
where [η] is the intrinsic viscosity and K and α are charac-
teristic parameters for each polymer-solvent system. 
K and α parameters take values of 0.082 mL g−1 and 0.76, 
respectively.[20] Thus, chitosan exhibited Mη of 511 kDa 
with 24% of DA.
2.2. Fumarate Copolymer Synthesis
Radical copolymerization of VA with DIPF, was carried out in 
bulk, initiated by BP under microwave energy, following the 
methodology previously reported.[21] Briefly, both monomers 
(DIPF:VA, 75:25) together with the previously weighed mass of the 
initiator (40 × 10−3 m) were charged into a reaction vessel and then 
purged with N2 during 30 min. Reaction vessels were irradiated at 
140 W during 25 min using a microwave oven (Zenith, ZVP-2819) 
of 2450 MHz microwave frequency and 700 W maximum power. 
After reaching room temperature, the copolymer was isolated 
by hexane addition, purified by solubilization–precipitation 
(chloroform:hexane, 1:7), and then dried at constant weight for 
conversion estimation. The copolymer was designed as diiso-
propyl fumarate-vinyl acetate copolymer (PFV).
In order to introduce a hydroxyl group in to the main 
macromolecular chain, PFV was submitted to basic hydrolysis. To 
this end, the polymer was suspended in methanol (15% wt/v) and 
1% wt/v NaOH solution was added (50 mL NaOH/15 g polymer); 
then the solution was stirred at 50 °C for 1 h. After the reaction, 
the methanol was evaporated under vacuum, and the resulting 
solid was washed with water and dried until constant weight. This 
copolymer was designed as diisopropyl fumarate-vinyl acetate 
copolymer hydrolized (PFVH).
2.3. Scaffolds Preparation
To obtain the scaffold a 50% w/w mixture of chitosan (CHI, Sigma-
Aldrich, high molecular weight) and the previously synthesized 
copolymer were cross-linked in situ with borax by adaptation of 
the methodology of Sreedhar et al.[22] Briefly, a PFVH copolymer 
solution in acetic acid (1% wt/v) was added to the same volume 
of 1% wt/v of chitosan in dilute acetic acid (3% v/v) with con-
tinue agitation. Then, borax (4% wt/wt of the mixture of PFVH/
CHI) was added in order to carry out the cross-link. Finally, the 
blend was sonicated for 5 min and the obtained gels were casted 
by evaporating the solvent at room temperature on Teflon molds 
or culture plates. After drying, the membranes were neutralized 
with NaOH (5% wt/v). This sample was designed as PFVH-CHI-B. 
For comparison purposes, a physical mixture between PFVH and 
CHI was prepared. The obtained gels were casted by evaporating 
the solvent (acetic acid) at room temperature and dried under 
vacuum up to constant weight. For the experiments, the scaffolds 
were sterilized by UV exposure for 30 min.
2.4. Characterization of Materials
1H NMR spectra of polymers were recorded with aVariam-200 
MHz (Mercury 200) at 35 °C in acetonitrile-d3 or acetone-d6 for 
PFV or PFVH, respectively. Tetramethylsilane was used as an 
internal standard.
The FTIR spectra of the polymer films were recorded on a 
Nicolet 380 FTIR spectrometer between 4000 and 400 cm−1 
with a resolution of 4 cm−1 and 32 accumulated scans. Briefly, 
a polymer solution in chloroform (5.0 wt%) was prepared and 
poured onto the sodium chloride window. Then the solvent was 
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allowed to evaporate at room temperature, with the resulting 
film dried under vacuum until the weight remained constant. 
The EZ-OMNIC software was used to analyze the spectra.
The molecular weight distribution and the average molecular 
weights were determined by size exclusion chromatography (SEC) 
using a LKB-2249 instrument at 25 °C. A series of four μ-Styragel 
columns, ranging in pore size 105, 104, 103, 100 Å, was used 
with chloroform as an eluent. The sample concentration was 
4–5 mg mL−1 and the flow rate was 0.5 mL min−1. The polymer was 
detected by the carbonylic absorption of the ester group (5.75 μm), 
using an infrared detector (Miram 1A Infrared Analyzer) and the 
calibration was done with poly(methyl methacrylate) standard 
supplied by Polymer Laboratories and Polysciences.
The fractured sections of the scaffolds were obtained in 
liquid nitrogen using a razor blade, immediately afterward they 
were sputter with gold and their morphology was examined 
using scanning electron microscopy (SEM; Phillips 505, The 
Netherlands), with an accelerating voltage of 20 kV. The images 
were analyzed using Soft Imaging System ADDAII. The scaffolds 
surface was also examined by SEM.
Glass transition temperatures (Tg) were measured using a 
differential scanning calorimeter (Shimadzu-TA60). Samples 
(≈5 mg) were weighed and scanned at 10 °C min−1 from −30 to 
150 °C under dry nitrogen (30 mL min−1). Three consecutive scans 
were performed for each sample: heating/cooling/heating.
2.5. Stability and Degradation Assays
The enzymatic degradation behavior of PFVH-CHI-B and PFVH-
CHI scaffolds was assessed by individually immersing the 
pre-weighed scaffolds in 10 mL phosphate-buffered saline (PBS, 
0.01 m, pH 7.4) solution with or without 115 U/L lipase (EC 3.1.1.3, 
from Pseudomonas sp., Sigma) incubated at 37 °C for different 
periods of time (7, 15, and 45 d). All the prepared solutions were 
sterilized using a 0.2 μm syringe filter and kept until usage at 
4 °C. For each condition a minimum of four samples was tested. 
All solutions were changed weekly. At the end of each degrada-
tion period, the samples were removed from the solution, rinsed 
with distilled water and weighted at constant weight.
2.6. Mechanical Properties
The tensile properties of the scaffolds were determined with a 
universal testing machine (DigimessTC500), using a force load 
cell (“Interface” of Arizona, USA, SM-50 N capacity) under con-
trolled humidity conditions at 25 °C using a custom-build envi-
ronmental chamber, following the methodology previously 
described.[23] The dog bone shaped specimens (50 × 18 mm2) 
were tested at a rate of 5 mm min−1 until breaking point. Ulti-
mate tensile stress, elastic modulus, and elongation at breaking 
point were calculated on the basis of the generated tensile 
stress–strain curves. The results presented are the mean values 
of eighteen independent measurements.
2.7. Swelling Behavior
The maximum swelling and water absorption capacity of the 
scaffolds were determined as it was previously reported.[24] The 
water content of the membrane was obtained as the difference 
between w and w0, where w was the weight of the water-satu-
rated sample and w0 was the weight of the initial dried sample. 
The percentage of swelling of the membrane was defined as






In order to have insights into the water transport process 
through the scaffolds, the following equation was used to 





t n  (4)
where k is a characteristic constant of the system, which depends 
on the structural characteristics of the polymer and its interaction 
with the solvent, n is the swelling exponent, which describes the 
mechanism of water transport into the membrane, while wt and 
w∞ represent the quantities of water absorbed at time t and at 
equilibrium time, respectively. In the above equation the numer-
ical value of n provides information about the water sorption 
mechanism. An n value of 0.5 indicates Fickian kinetics where the 
rate of diffusion of water is the limiting process, while a value of 
n between 0.5 and 1.0 indicates a non-Fickian diffusion process 
in which the relaxation of polymer chains determines the rate of 
water sorption. The limit case (designed as Case II transport where 
n = 1) corresponds to a condition in which the rate of water diffu-
sion is higher than the rate of polymer chain relaxation. In this con-
dition the rate of mass uptake is directly proportional to time.[26] 
The value of n can be obtained from the slope, while k is obtained 
from the interception of the plot of log(wt/w∞) versus log t from 
the experimental data, taken until 60% of the maximum swelling.
2.8. Biocompatibility Studies
2.8.1. Cell Cultures and Incubations
For biocompatibility assays BMPC and chondrocyte cells were 
used. BMPC were isolated from the femora of Sprague-Dawley rats 
and cultured according to Molinuevo et al.[27] Cells were main-
tained in basal media (DMEM-10% FBS) at 37 °C. Cell adhesion 
and proliferation was evaluated by the 3-(4,5-dimrthylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. This assay 
measures the reduction of the tetrazolium salt MTT to formazan 
by intact mitochondria in living cells. Thus, absorbance change 
is directly proportional to the number of viable cells. Briefly, 
2.5 × 104 cells per well in basal media were plated onto the scaf-
folds which were casted on multiwell culture plates and cultured 
during different periods of time: 1 h (adhesion, proliferation 0 d), 
or 1, 3, and 7 d (proliferation). After these culture periods, cells 
were incubated for two additional hours with a solution of 
0.1 mg mL−1 MTT. After washing, the formazan precipitate was 
dissolved in dimethyl sulfoxide (DMSO) and the absorbance read 
at 570 nm.
Alternatively, chondrocytes were isolated from the xiphoid 
process of the sternum of Sprague-Dawley adult rats after 
dissection of the perichondrium. Briefly, the cartilage was 
minced, washed three times in phosphate saline buffer pH 7.4 
(PBS), and treated with trypsin for 15 min at 37 °C. After that 
cartilage was washed three times with DMEM-10% FBS and 
maintained in culture at 37 °C under 95% air and 5% CO2 with 
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half of the culture media changed every 3 d.[28] After 28 d, 
chondrocytes outgrowths from the cartilage were replated on the 
scaffolds and the mitogenic assay was conducted as described in 
the precedent paragraph.
All procedures were in accordance with the Guide for the Care 
and Use of Laboratory Animals published by the National Institutes 
of Health, and they were approved by the Institutional Laboratory 
Animal Care and Use Committee (CICUAL Protocol No. 001-05-15).
2.8.2. Osteoblastic Differentiation
Osteogenic induction of BMPC was performed by incubating the 
cells in basal media plus β-glycerol-phosphate and ascorbic acid 
during different periods of time as previously reported.[27] After 
15 d type I collagen was evaluated through the colorimetric assay 
with Sirius red and after 21 d mineral deposits were analyzed 
with the colorimetric assays of Alizarin S red.
2.8.3. Chondroblastic Assays
To evaluate the cartilage extracellular matrix produced by chon-
drocytes we determined the proteoglycans deposits after 21 d by 
the colorimetric method using alcian blue pH 3.5. Briefly, cells 
were fixed with formalin during 15 min and stained overnight 
with alcian blue pH 3.5. After washing, the stained material was 
detained with 4 m guanidine hydrochloride. The absorbance was 
determined at 570 nm.
2.8.4. Evaluation of Reverse Transcription-Polymerase 
Chain Reaction (RT-PCR) Gene Expression of Osteogenic 
and Chondrogenic Markers
Total RNA was isolated from cultured stem cells and chondrocytes 
by the TRIZOL reagent method as suggested by the manufacturer 
(Invitrogen, Argentina). The RNA expression of osteogenic 
markers (alkaline phosphatase (ALP), Runx2, and type I collagen 
(Col1a)) and chondrogenic markers (type II collagen (Col2), 
aggrecan, and SOX9) were analyzed using the semiquantitative 
RT-PCR using MMLV-RT (PB-L Productos Bio-Logicos, Argentina). 
All the markers were normalized using β-actin as housekeeping. 
The specific primers for the markers were designed from NCBI 
sequence data, using CLC Genomics Workbench software 
(QIAGEN) (Table 1) and band intensity was quantified using the 
gels plugin of MBF_ImageJ progam. The results of the PCR semi-
quantitative analysis were expressed as relative intensity, and 
represent the quotient of the signal intensity of a specific band of 
each marker and the signal intensity of β-actin as housekeeping.
2.8.5. Evaluation of Cytotoxicity
The eventual cytotoxicity of the biomaterial was evaluated by 
measuring nitric oxide (NO), interleukin-1β (IL1β), and tumor 
necrosis factor α (TNFα) production using a model of macrophages 
in culture. Briefly, RAW264.7 macrophages were grown on the 
scaffolds or the tissue culture plates (control condition) in DMEM 
without phenol red-5% FBS. After 24, 48, and 72 h the supernatants 
were collected and evaluated for NO production by the Griess’ assay. 
IL1β and TNFα production were evaluated by ELISA kits (BD OptEIA 
mouse IL-1β ELISA and BD OptEIA mouse TNF (Mono/Mono) ELISA 
set) in the conditioned media 2, 7, and 13 d of incubation.
2.9. Statistical Analysis
Results are expressed as the mean ± SEM and, unless indicated 
otherwise, were obtained from two separate experiments per-
formed in triplicate. Differences between groups were assessed by 
one-way ANOVA with Tukey post hoc test. For non-normal distrib-
uted data nonparametrical Kruskal–Wallis with Dunn’s post hoc 
test was performed, using Graph Pad InStat v. 3.00 (Graph Pad Soft-
ware, San Diego, CA, USA). p < 0.05 was considered significant for 
all statistical analyses.
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Table 1. Primer sequence for osteo- and chondrogenic markers.
Marker Genbank code Product size (bp) Sequence
β-actin NM_031144.3 345 fw CCTTCAACACCCCAGCCAT
rv CATAGCTCTTCTCCAGGGA
RUNX2 XM_006244554.2 598 fw GCCGGGAATGATGAGAACTA
rv TGAGAGAGGAAGGCCAGA
ALP J03572.1 737 fw GACAGCAAGCCCAAGAGA
rv CAGTTCAGTGCGGTTCCA
Col1a1 NM_053304.1 651 fw GCATACACAATGGCCTAA
rv CTGTTCCAGGCAATCCAC
Col2 NM_012929.1 295 fw GGGCAGAAAGGAGAACCT
rv TTGCATGACTCCCATCTGG
SOX9 NM_080403.1 503 fw TCTCCTGGACCCCTTCAT
rv GGTGGTCTTTCTTGTGCT
Aggrecan NM_022190.1 525 fw CCATCCCCTGCTACTTCATC
rv CACCATAGCAACCTTCCC
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3. Results and Discussion
3.1. Copolymer Synthesis and 
Characterization
Based on our previous experience, we 
performed the synthesis of diisopropyl 
fumarate-vinyl acetate copolymer (PFV) 
by radical copolymerization under 
microwave conditions. The known 
advantage of such methodology was 
previously applied for other similar sys-
tems in our group, where we demon-
strated that the rate of polymerization 
has been significantly faster than under 
thermal conditions.[18,21] In the present 
case, the reaction conversion attaining 
at 140 W and 25 min of reaction time 
was 40%. On the other hand, the selec-
tion of the comonomers was based on 
the prior knowledge of the properties of 
fumaric copolymers, such as hydropho-
bicity/hydrophilicity ratio, stability, and 
glass transition temperature.[29,30] The 
structure of the obtained copolymer PFV starting of 75:25 
(DIPF:VA) feed monomer compositions under microwave 
conditions were confirmed by FTIR and 1H NMR. FTIR (thin 
film, cm−1): 2979, 2931, 2877 (CH alifatic), 1730 (CO), 
1233 and 1106 (COOR). Figure 1 shows the 1H NMR spec-
trum including the structure and the peaks assignation, 
based on the corresponding homopolymers spectra. 1H 
NMR (CD3CN): δ (ppm), 1.26 (CH3), 1.97 (CH2), 2.19 
(CH3CO), 2.97 (CH<), 4.98 (OCH(CH3)2).
Composition of PFV was estimated from the integral 
ratio of the peak at 1.26 ppm corresponding to methyl 
hydrogen (CH3) of DIPF unit and the peaks between 
1.4 and 2.2 ppm corresponding to methylene and methyl 












where FDIPF is the mole fraction of DIPF in the copolymer 
and I1 and I2 represent the 1H NMR resonance peak areas 
at 1.26 ppm and near to 2.0 ppm, respectively. Based on 
this analysis, the FDIPF of PFV was 0.68. The weight-average 
molecular weight (Mw) and polydispersity index were 
42600 g mol−1 and 6.4, respectively, evaluated through SEC 
according to the ratio Mw/Mn.
Then, PFV copolymer was partially hydrolyzed in 
order to increase its hydrophilicity for a better inter-
action with chitosan. It was formerly reported that 
acid and alkaline hydrolyses of poly(DIPF) to obtain 
poly(hydroxycarbonylmethy1ene) were very difficult, 
due to the steric effect of the bulky group on the macro-
molecular chain.[31] Thus, under the selected experi-
mental conditions, only the VA ester groups can be hydro-
lyzed (see Scheme 1).
The structure of PFVH was demonstrated by FTIR and 
1H NMR spectroscopic analysis. FTIR (thin film, cm−1): 
3438 (OH), 2979, 2931, 2877 (CH alifatic), 1730 (CO), 
1233 and 1106 (COOR), 666 (δout plane, OH). Figure 2 
shows the 1H NMR spectrum including the structure and 
the peaks assignation. 1H NMR (CD3COCD3): δ (ppm), 1.32 
(CH3), 2.07 (CH2–;CH3CO), 2.96 (HOCH<; CH<), 
5.03 (OCH(CH3)2). As it can be seen in this figure, there 
is a broad peak close to 3 ppm similar to the peak that 
appears in the 1H NMR spectrum of PFV. However, it is 
overlapped with another sharp peak assigned to the VA 
unit hydrolyzed together with the disappearance of CH3 
signal at 2.2 ppm. Both observations together with the 
OH band (3438 cm−1) of FTIR spectrum, confirm the effi-
ciency of the hydrolysis reaction.
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Figure 1. 1H NMR spectrum of PFV in acetonitrile-d3 at 35 °C. The inset shows the cor-
responding copolymer structure with peak assignation.
Scheme 1. Hydrolysis reaction of PFV to produce PFVH. As it was 
described in the Experimental Section, hydrolysis reaction was 
carried out under basic methanolic conditions at 50 °C during 1 h.
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3.2. Scaffolds Preparation and Characterization
One of the most important issues related to the polymer 
blend preparation is its compatibility, which is closely 
related to the polymer–polymer interactions. In particular, 
numerous chitosan-based blends were prepared using 
different methodologies, among which we can highlight 
the use of cross-linking agents. For example, chitosan/
poly(vinyl alcohol) was cross-linked 
with borate, tripolyphosphate and glu-
taraldehyde.[13] In the present work 
we have selected borate as cross-linker 
agent. This reagent is able to form a 
complex between tetrahydroxyborate 
ion and various polyols, a kind of inter-
action that it is not limited to hydroxyl 
groups on adjacent carbon atoms but can 
also involve those on alternate carbon 
atoms.[32] Thus, we expect that borax act 
as cross-linker agent forming a complex 
between the hydroxyl groups of both 
polymers, PFVH and CHI.
To evaluate polymer compatibility, 
we first studied the surface of the scaf-
fold by SEM comparing the mixture of 
PFVH with chitosan (PFVH-CHI) before 
(Figure 3A,B) and after the addition of 
Borax (Figure 3C,D). We found that PFVH-
CHI scaffolds without borax have a scaly 
surface (Figure 3A) with evident signs 
of phase separation in the fracture edge 
(Figure 3B, arrow). On the other hand, 
the PFVH-CHI-B scaffold presented a 
rough homogeneous surface (Figure 3C) 
and the same structure seems to con-
tinue in the breaking surface (Figure 3D).
The glass transition temperature (Tg) 
was determined by differential scan-
ning calorimetry. Figure 4 show the 
diferential scanning calorimetry (DSC) 
analysis of PFV, PFVH copolymers, and 
PFVH-CHI-B sample including 4% of 
borax. PFVH exhibited an increase of Tg 
(60.5 °C) in comparison to PFV (48.3 °C), 
which can be attributed to a decrease in 
chain structure flexibility, due to intra/
interchain hydrogen bond. No modifica-
tion of Tg was observed for the physical 
blend (PFVH-CHI, data no shown) com-
pared to PFVH. On the other hand, the 
caloric behavior of PFVH-CHI-B sample 
is less clear but an increase in the Tg of 
4.3 °C was observed. These results sug-
gest that the borax produce the cross-
linking between the PFVH and CHI polymers, which 
restricts the catenaries movements, as it was previously 
observed for other related systems.[13,33]
3.3. Stability and Degradation
We have also evaluated the stability and the possible 
degradation of the scaffolds in phosphate saline buffer 
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Figure 2. 1H NMR spectrum of PFVH in acetone-d6 at 35 °C. The inset shows the 
corresponding copolymer structure with the peak assignments.
Figure 3. SEM images of PFVH-CHI and PFVH-CHI-B. The surface characteristics and the 
breaking surface of A,B) PFVH-CHI or C,D) PFVH-CHI-B scaffolds.
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pH 7.4 at 37 °C. We found a linear increase in the weight 
loss for both PFVH-CHI and PFVH-CHI-B with a maximum 
of about 10% of weight loss after 45 d of incubation, 
without differences between PFVH-CHI and PFVH-CHI-B 
scaffolds (Figure 5A). However, the enzymatic degradation 
rate for PFVH-CHI-B scaffolds was significantly lower than 
the PFVH-CHI rate during the short times (7 and 15 d) but 
reaching similar levels at 45 d (Figure 5B). Moreover, the 
maximum % of weight loss was similar to those obtained 
in PBS (Figure 5A). It is known that chitosan is susceptible 
to be degraded in vivo by lipase, which appear to target 
acetylated residues.[10,34] This process is dependent on 
the acetylation degree of chitosan, where low degree of 
acetylated samples exhibited a relatively low degradation 
rate. In our system we can attributed the low degrada-
tion rate to chitosan, the only polymer which can suffer 
an enzymatic degradative process. This hypothesis could 
also explain the similar degradation behavior of the scaf-
folds under hydrolytic conditions, but also it allows us to 
hypothesize that the cross-linking borax is affecting the 
degradation rate of chitosan. It has been previously dem-
onstrated in related blends of chitosan that their degrada-
tion can be attributed to the degradation of chitosan rather 
than to other compounds presents on the blends.[35]
3.4. Mechanical Properties
The mechanical performance of PFVH-CHI-B and PFVH-
CHI scaffold were analyzed by traction test. The tensile 
strength, elongation at break, and elastic modulus were 
10 ± 2 MPa, 6.0% ± 1.0%, and 344 ± 38 MPa, respectively, 
for PFVH-CHI-B. In comparison, the tensile strength, elon-
gation at break, and elastic modulus for the PFVH-CHI 
scaffold were 11 ± 2 MPa, 5.6% ± 0.7% and 407 ± 30 MPa, 
respectively. There were no significant differences on these 
parameters studied between the scaffolds with or without 
borax, which could be explained by the low cross-linked 
rate of the networks because of the low borax proportion 
used in our matrices. These results are consistent with 
data previously showed in the DSC studies where small 
differences were found between the PFVH-CHI and PFVH-
CHI-B scaffolds. Moreover, our results are comparable 
to the mechanical properties of other structural related 
systems[13] but compared to the articular cartilage they 
present the highest modulus due to the absence of intern 
porous, as it was proved by other researches.[36,37]
3.5. Swelling
Figure 6 presents the swelling kinetics of the PFVH-CHI-B 
scaffolds in buffered aqueous solutions of pH 7.4 at 37 °C. 
In this figure it can be observed that the degree of swelling 
increases with time, until a certain point where it becomes 
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Figure 4. DSC thermograms of the copolymer PFV; PFVH, the 
hydrolysis product of PFV and the PFVH borax-cross-linked 
chitosan scaffold, PFVH-CHI-B.
Figure 5. Scaffold degradation study. PFVH-CHI and PFVH-CHI-B 
degradation behavior was evaluated in A) buffer pH 7,4 and 
B) lipase solution at 37 °C during different periods of time. 
*p < 0.05 versus PFVH-CHI, n = 5.
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constant, reaching equilibrium within 30 min. The max-
imum swelling attained was 303%, which is a typical value 
for hydrogels.[38,39]
During the swelling process the water molecule diffuse 
into the polymer matrix acting as plasticizers and pro-
moting the relaxation of the macromolecular chains. As 
it was previously mentioned, the kinetics of such process 
could be analyzed through the Fick model (Equation (4)) in 
order to determine the n exponent. The inset in Figure 6 
shows the linear regression plots of the fractional-water 
absorbed at short times according to Equation (4), from 
which the n value of 0.809 could be calculated. This result 
suggests that the mechanism of water transport within 
the scaffold occurred by a non-Fickian diffusion process, 
probably with a rapid water diffusion in comparison to 
the macromolecular chain relaxation.
3.6. Biocompatibility Studies
Then, we evaluated the growth kinetic of BMPC and pri-
mary chondrocytes to investigate the biocompatibility 
of the PFVH-CHI-B scaffold (Figure 7A,B, respectively). We 
found that both cell lines growth in a similar way on the 
scaffold and on the tissue culture plates. However, the 
growth of BMPC was time-dependent with a saturation 
of the hyperbolic curve after 2 d of culture when cells are 
growing on culture dishes, while the cells growing on the 
scaffold continues growing up to 7 d (Figure 7A). On the 
other hand, the chondrocytes had a lag time and after 
that there was an exponential increase in cell number 
(Figure 7B).
Then we evaluated the capacity of BMPC to differen-
tiate toward an osteoblastic phenotype when growing 
on the scaffold. We found that BMPC growing on the 
scaffolds produced significantly higher amounts of type I 
collagen or mineral nodules after 15 or 21 d, respectively, 
of osteoblastic differentiation compared to BMPC differ-
entiated on the tissue culture plates (Figure 8A, p < 0.01). 
We also evaluated the mRNA expression of different oste-
oblastic markers Runx2, ALP, and Col1a by RT-PCR. The 
analysis of the PCR bands showed that that the expres-
sion of all markers in the BMPC remain unchanged after 
15 d of culture with osteogenic media on tissue culture 
dishes (plastic, P) or on the scaffold (SC) (Figure 8B,C).
Chondrocytes growing on the scaffold showed a 
denser disposition than those growing on tissue culture 
plates (Figure 9A). Additionally, we found that primary 
chondrocytes growing on the scaffold produced higher 
amounts of the proteoglycan matrix than cells growing 
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Figure 6. Swelling kinetic of the PFVH-CHI-B scaffold was studied 
in phosphate-saline buffer pH 7.4 at 37 °C.
Figure 7. Cell proliferation assays. Time course of A) BMPC and 
B) chondrocyte cell growth was evaluated by MTT assay as it was 
described in the Experimental Section. Results are expressed as % 
Basal (0 d of proliferation), n = 6.
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on tissue culture plates (Figure 9B). Evaluation of the 
mRNA for chondroblastic markers showed that Col2 and 
SOX9 levels were similar for chondrocytes growing on 
both plastic and PVFH-CHI-B (SC). Contrary, cells growing 
on the PVFH-CHI-B scaffolds expressed significantly 
higher levels of aggrecan than the cells growing on plastic 
(Figure 9C,D, respectively, p < 0.05). Thus, the scaffold-
induced up-regulation of different markers could have 
different kinetics at mRNA levels.
Nevertheless, our results suggest that this novel bio-
material presents enough versatility to be used on the 
osteochondral interface regeneration. Previous data 
demonstrated that chitosan-based scaffolds presented 
good biocompatibility allowing both chondrocyte and 
osteoblast development.[40–43] It has been previously 
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Figure 8. Osteoblastic differentiation. A) BMPC were cultured 
in an osteoblastic differentiation media and collagen type I 
(after 15 d) or mineral nodules (21 d) production were evaluated. B) 
Semiquantitative analysis of mRNA for Runx2, ALP, and collagen 
type I after 7 d of differentiation. C) The PCR products of Runx2, 
alkaline phosphatase, collagen type I, and actin for BMPC growing 
on plastic (P) or PVFH-CHI-B (SC), respectively. ** p < 0.01, n = 5.
Figure 9. Chondrogenesis was evaluated by the assessment 
of glycosminoglycan (GAG) production. Primary chondrocytes 
growing on A) plastic or PVFH-CHI-B matrix were stained with 
alcian blue after 21 d of culture, and B) the production of GAG was 
evaluated spectrophotometrically. The expression of molecular 
markers for chondrogenic development was evaluated by PCR 
after 10 d of culture C,D) for chondrocytes growing on plastic (P) 
or PVFH-CHI-B (SC). * p < 0.05, n = 5.
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reported that chitosan blends with synthetic polymers 
or ceramics improve osteo- or chondroblast growth and 
development. However, there are few reports about scaf-
folds that supports both osteoblastic and chondroblastic 
development.[11,43] In this sense, our scaffold represents 
an improving on the chitosan-based biomaterials because 
it allows the in vitro development and differentiation of 
both osteoblasts and chondrocytes.
3.7. Cytotoxicity Studies
Finally, we also investigate if our scaffolds might generate 
any cytotoxic effect using RAW264.7 macrophages in culture 
and evaluating the cytokine (NO, IL1β, and TNFα) produc-
tion during different times. Macrophages have the capacity 
to react toward foreign bodies producing inflammation 
mediators such as IL, TNFα, and NO, and thus represent a 
good model to investigate the cytotoxicity of biomaterials. 
In the present work, we found no differences on nitric oxide 
production after the cells were grown on the scaffolds or in 
control condition (standard culture dishes) (Table 2). Similar 
results were obtained for IL1β and TNFα (Table 3). Although 
there was an increase in cytokine secretion as a function of 
time of culture, this increase was found under the control 
condition as well as on cells growing on the scaffold with 
no statistical differences between them. One of the reasons 
for the interest on chitosan-based biomaterials is the low 
cytotoxicity of chitosan.[44] On the other hand, we have also 
previously demonstrated the in vitro biocompatibility and 
low toxicity of polyfumarates and chitosan-based mate-
rials.[23,45–48] However, cross-linking improves the proper-
ties of the biomaterials, but most cross-linkers either cause 
undesirable changes to the functionality of the biopolymers 
or result in cytotoxicity. Although we used borax, which is 
considered a low cytotoxic cross-linker, we investigated the 
cytotoxicity of the biomaterial obtained.[16] In this work, 
we used the monocyte-macrophage RAW264.7 cells, to 
demonstrate that the combination of these two materials 
using borax to obtain the new cross-linked material did not 
generate any toxicity.
4. Conclusions
In conclusion we have obtained and characterized a 
borax cross-linked chitosan and vinyl acetate-fumarate 
copolymer-based biomaterial for osteochondral tissue 
engineering. This cross-linked biomaterial could be con-
sidered as a hydrogel based in its swelling behavior with 
mechanical properties between bone and cartilage tissue. 
Biocompatibility studies demonstrate the versatility of this 
material since it allows BMPC osteogenic development and 
supports primary chondrocytes growth and extracellular 
matrix deposition. Moreover, we demonstrated that this 
cross-linked scaffold presented low cytotoxicity and could 
be degraded slowly to meet the requirements of osteo-
chondral tissue reparation.
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